Stem cell based strategies are therapeutically potent for treating type-1 diabetes mellitus owing to their intrinsic regenerative capacity and immunomodulatory properties to arrest autoimmune β-cell destruction, preserve residual β-cell mass, facilitate endogenous regeneration, ameliorate innate/ alloimmune graft rejection, restore β-cell-specific unresponsiveness in absence of chronic immunosuppression and to reverse hyperglycemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.diabres.2017.04.014 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!